Date: Sunday, October 21, 2018
Session Type: ACR Poster Session A
Session Time: 9:00AM-11:00AM
Background/Purpose: Systemic lupus erythematosus(SLE) is multisystem disorder that is caused by tissue damage resulting from antibody and complement-fixing immune complex deposition. Lupus nephritis(LN) is frequent complication and one of the most serious manifestations of SLE. The alteration of the structural protein in podocytes is known as a mechanism of proteinuria in LN. The signaling lymphocyte activation molecule family(the SLAM family) of typeⅠtransmembrane receptors consists of nine related members of the immunoglobulin superfamily and has been reported to mediate important regulatory signals between immune cells through their homophilic and heterophilic interactions(Nat Rev Immunol. 2003 Oct;3(10):813-21).The 1q23 region on human chromosome 1 including the SLAMF cluster of genes, containing SLAMF6 has been identified as a lupus susceptibility locus(Nat Rev Rheumatol. 2010 Jun;6(6):348-57).It has been shown that the expression of signaling lymphocyte activation molecule family 6(SLAMF6) is enhanced in CD4+T cells of SLE patients and is involved in IL-17 production(J Immunol 2012; 188:1206-1212). We sought to examine the functional role of SLAMF6 in lupus podocytes.
Methods: We evaluated the co-expression of nephrin, a podocyte marker and SLAMF6 in kidney of normal controls and LN patients, also in B6 and MRL/lpr mice at the age of 8wk and 16wk by immunofluorescence analysis. We also examined nephrin positive SLAMF6 expression in isolated podocytes from B6 and MRL/lpr kidneys. Then, we analyzed the expression of SLAMF6 in CD4+T cells of isolated kidney and spleen in B6 and MRL/lpr mice. We treated human podocytes with IgG from healthy individuals and LN patients for 24 h and 48h and analyzed the expression of SLAMF6 by real-time PCR.
Results: In the histopathology, the expression of SLAMF6 was increased in nephrin positive area in LN patients and MRL/lpr mice compared to control. Although the expression of nephrin in MRL/lpr mice kidney at 16 wk old decreased compared to B6 mice at same age, the expression of SLAMF6 in podocytes increased in diseased MRL/lpr mice compared to B6 mice. Similarly, the expression of SLAMF6 in CD4+ T cells increased in diseased MRL/lpr mice kidney and spleen compared to B6 mice. The level of SLAMF6 mRNA elevated in human podocytes exposed to LN-derived IgG.
Conclusion: The expression of SLAMF6 is enhanced in LN podocytes, suggesting that the possibility of cooperating with CD4+T cells contributing to its dysfunction. Further examination is needed to nvestigate in detail how SLAMF6 is involved in the development of LN in the future.
To cite this abstract in AMA style:Igawa T, Ichinose K, Umeda M, Koga T, Eguchi M, Okamoto M, Endo Y, Tsuji S, Takatani A, Shimizu T, Fukui S, Sumiyoshi R, Kawashiri S, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Tsokos GC, Kawakami A. Expression of SLAMF6 and Its Functional Significance in Podocytes of Lupus Nephritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/expression-of-slamf6-and-its-functional-significance-in-podocytes-of-lupus-nephritis/. Accessed .
« Back to 2018 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/expression-of-slamf6-and-its-functional-significance-in-podocytes-of-lupus-nephritis/